Improving medication safety for older adults with Alzheimer's and related dementias
Official title: The U.S. Deprescribing Research Network
Funded at Northern California Institute/res/edu · NIH-11141896 · Data updated 2026-11-12
This study is all about finding better ways to help older adults with Alzheimer's and related dementias safely reduce or stop medications that they might not need, so they can feel better and avoid any harmful side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | August 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $809,610 |
| NIH project number | 5R33AG086944-02 |
| Project ID | NIH-11141896 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults diagnosed with Alzheimer's disease or related dementias who are currently taking multiple medications.
✕Less likely to help
Patients who are not diagnosed with Alzheimer's disease or related dementias, or those who are not on multiple medications, may not benefit from this research.
What this research studies
This research focuses on deprescribing, which is the process of safely reducing or stopping medications that may be unnecessary or harmful for older adults, particularly those with Alzheimer's disease and related dementias. The project aims to develop new methods and collaborations to enhance the understanding and implementation of deprescribing practices. By engaging a network of interprofessional investigators, the research seeks to create educational programs and pilot projects that will lead to better medication management for vulnerable older adults. The ultimate goal is to improve patient outcomes by minimizing adverse effects from inappropriate medication use.
Why it matters
Potential benefit: If successful, this research could lead to safer medication practices and improved quality of life for older adults with Alzheimer's and related dementias.
How similar studies have gone: Previous research has shown promise in deprescribing practices, indicating that this approach could lead to significant improvements in patient care.
Where this research is happening
-
Northern California Institute/res/edu
San Francisco, United States Active
Researchers
- Principal investigator: Steinman, Michael a. — Northern California Institute/res/edu
- Study coordinator: Steinman, Michael a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.